CareFusion Corp (CFN): Today's Featured Health Services Winner
CareFusion (CFN) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 1.6%. By the end of trading, CareFusion rose $1.29 (5%) to $27.09 on heavy volume. Throughout the day, six million shares of CareFusion exchanged hands as compared to its average daily volume of 1.7 million shares. The stock ranged in a price between $25.59-$27.26 after having opened the day at $25.83 as compared to the previous trading day's close of $25.80. Other companies within the Health Services industry that increased today were: IsoRay (ISR), up 14.6%, American Caresource Holdings (ANCI), up 14.6%, Escalon Medical Corporation (ESMC), up 10.5%, and CAS Medical Systems (CASM), up 6%. CareFusion Corporation, a medical technology company, provides various healthcare products and services in the United States and internationally. It operates in two segments, Critical Care Technologies, and Medical Technologies and Services. CareFusion has a market cap of $5.89 billion and is part of the health care sector. The company has a P/E ratio of 13.9, below the average health services industry P/E ratio of 20.3 and below the S&P 500 P/E ratio of 17.7. Shares are up 3.1% year to date as of the close of trading on Thursday. Currently there are eight analysts that rate CareFusion a buy, no analysts rate it a sell, and four rate it a hold. TheStreet Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.
- You can view the full CareFusion Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Latest Headlines about CFN
-
Markets Close Higher as Bernanke Signals Support
04:42PM 05/10/13
-
A Lower Stock Price Never Turns A Bad Company Into A Good One
06:56AM 03/27/13
-
Generic Drugmaker Mylan Is A Smart Healthcare Play
11:30PM 03/19/13
-
CareFusion's Technologies Meet Health Care Needs
06:30AM 02/13/13
-
Cramer's Top Stock Picks: HMST CCL CFN AAPL
06:00AM 02/09/13
-
Cramer's 'Mad Money' Recap: Next Week's Game Plan
08:13PM 02/08/13
-
CareFusion Management Discusses Q4 2012 Results - Earnings Call Transcript
09:20PM 08/09/12
Latest from TheStreet Wire
-
Abbott Laboratories (ABT): Today's Featured Health Services Laggard
05:22PM 06/19/13
-
Petroleo Brasileiro SA Petrobras (PBR): Today's Featured Basic Materials Laggard
05:01PM 06/19/13
-
Microsoft Corporation (MSFT): Today's Featured Computer Software & Services Laggard
05:01PM 06/19/13
-
Target Corp (TGT): Today's Featured Services Laggard
05:01PM 06/19/13
-
Teck Resources Ltd (TCK): Today's Featured Metals & Mining Laggard
05:01PM 06/19/13
-
United Technologies Corp (UTX): Today's Featured Industrial Laggard
05:01PM 06/19/13
-
Texas Instruments Inc. (TXN): Today's Featured Electronics Laggard
05:01PM 06/19/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
